Former Generic Executive Indicted For Price Fixing, Bid Rigging

(February 5, 2020, 12:12 PM EST) -- PHILADELPHIA — A former vice president at a New York generic drug manufacturer was indicted Feb. 4 for making a false statement and violating the federal antitrust law by conspiring to fix prices, rig bids and allocate customers (United States v. Ara Aprahamian, No. 20-cr-64, E.D. Pa.)....

Attached Documents

Related Sections